A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial - Concepedia

Concepedia

Publication | Closed Access

A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial

40

Citations

20

References

2014

Year

Daniela Baldoni, Shirin Bruderer, Andreas Krause, Marcello Gutierrez, Pierre Guéret, B Astruc, Jasper Dingemanse

Clinical Drug Investigation

First-in-man TrialPharmacologyNew ReversibleExperimental PharmacologyPharmacotherapyMedicinePharmacokinetics

References

	Year	Citations

Page 1